Investors → «Rock Springs Capital»
Rock Springs Capital
Investors
Invests into
Adaptimmune
Biomea Fusion
Bristol Myers Squibb
Caris Life Sciences
Cerevel Therapeutics
Delfi Diagnostics
ESCAPE Bio
Everest Medicines
Freenome
Genesis Therapeutics
Invitae
Kaleido Biosciences
ObsEva
Proteostasis Therapeutics
Pulmonx
Reneo Pharmaceuticals
Treeline Biosciences
Investors
David Hagen
Ellen Feldman
Taylor Beccone
Number Of Exists:
85
Employee Number:
51-100
ATinformation@rockspringscapital.com
https://www.linkedin.com/company/rock-springs-capital
Register and Claim Ownership